Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15230294 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: High-dose immunoablative therapy

Indicates status has not been verified in more than two years